Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
Past Issue

Vol. 10, No. 4
April 2004

Adobe Acrobat logo

EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

PDF Version | Comments Comments | Email this article Email this article



Acknowledgment
References
Figure 1
Figure 2

Letter

Newly Isolated Vibrio cholerae Non-O1, Non-O139 Phages

B.L. Sarkar*Comments Amar N. Ghosh,* Anindito Sen,* and D.P. Rodrigues†
*National Institute of Cholera & Enteric Diseases (ICMR) World Health Organization Collaborating Centre for Research and Training on Diarrheal Diseases, Kolkata, India; and †Instituto Oswaldo Cruz, Rio de Janerio, Brazil

Suggested citation for this article: Sarkar BL, Ghosh AN, Sen A, Rodrigues DP. Newly isolated Vibrio cholerae non-O1, non-O139 phages. Emerg Infect Dis [serial online] 2004 Apr [date cited]. Available from: http://www.cdc.gov/ncidod/EID/vol10no4/03-0413.htm


To the Editor: The epidemic cholera caused by Vibrio cholerae O1 appeared in Latin America in 1991 after a 100-year absence. Following its explosive appearance in Peru, travelers on the Amazon River brought cholera to Brazil by April 1991. It spread southward along the Atlantic Coast of Brazil, reaching Rio de Janeiro in February 1993.

Phage typing is a useful tool for studying the source or origin of V. cholerae for epidemiologic importance. Because of limitations of the Basu and Mukerjee scheme, a new phage-typing scheme for V. cholerae O1 was developed at the National Institute of Cholera and Enteric Diseases, India (1–3). During the course of a comprehensive study on the phage typing of V. cholerae O1, most strains isolated in Brazil were found to be sensitive with a set of 10 El Tor phages (ATCC 51352-B1–B10) (4). This finding prompted us to explore or ascertain the natural habitat of V. cholerae and cholera phages, if any, in an environmental reservoir in Brazil, particularly in Rio de Janeiro.

Samples were collected from selected points where sewage water connected with the main canal receives domestic and industrial effluents from the city on its way to the Atlantic Ocean. Two major environmental parameters, temperature and pH, were recorded at each station during collection. Samples were processed for phage isolation according to the procedure adopted for V. cholerae phages (5,6). Portions of the samples were also analyzed for enteric pathogens. A total of 32 sewage samples were collected in 8 months; 12 were isolated from Rio de Janeiro, 10 from the Amazon region in the North, and 10 from northeastern Brazil.

Each sample was divided into two parts; one section was used to isolate O1 phages using MAK 757 (ATCC 51352) as a propagating strain. The other portion was used for non-O1 phages; the non-O1 V. cholerae strain was used for propagation starting from O2 to O139. The procedure was repeated on nutrient agar for the appearance of plaques. The phages were purified from a single discrete plaque by the soft agar (0.8%) overlay method with the propagating strain of V. cholerae non-O1 (O2 to O139) until homogenous plaques were obtained. Phage lysates were prepared in nutrient broth (Difco Laboratories, Detroit, MI) with the propagating strain V. cholerae (both O1 and non-O1).

High-titer phages were obtained by the plate lysis procedure by using the agar overlay method (5) with multiplicity of infection 0.01 at an incubation temperature of 37°C. Concentration, purification, and electron microscopy study of these phages were performed as described by Ghosh et al. (1989) (7), using a FEI Tecnai 12 Bio Twin transmission electron microscope (FEI Europe BV, Eindhoven, Holland, the Netherlands). Measurements were made with Analysis (SIS GmbH, Munster, Germany) software. The homogeneity of each phage was studied by plaque morphology on nutrient agar following 10-fold serial dilution. Each high-titer phage (108–109 PFU/mL) was then used to determine routine test dilution (RTD) by the soft agar overlay method. In this experiment, the RTD used was the highest dilution that failed to give confluent or complete lysis. A variety of enteropathogens were included for susceptibility against these phages. A single colony from nutrient agar plate was injected into 5 mL of nutrient broth and incubated 2–3 h under stationary conditions at 37°C. A bacterial lawn was made on nutrient agar with this broth culture mixed with 3.5 mL of molten soft agar. The phage at RTD was spotted onto the plate and incubated at 37°C for 18 h. The next morning, the appearance of the zone of lysis was recorded. V. cholerae MAK 757 (ATCC 51352) was included as a positive control.

Of the 32 samples examined, two non-O1 phages (O6 and O34) sensitive to V. cholerae O6 and O34 were isolated from the same site, the Sarapui River in Rio. The plaques of both the phages were observed as clear and round, with a diameter of 3 to 4 mm. A total of 107 strains of Vibrio and Enterobacteriaceae were tested against these two phages. All strains were untypeable, except for the O6 and O34 serotypes, which were lysed by the phages specific for O6 (DR1) and O34 (DR2). During the study period, the recorded temperature was 25°C–38°C, and pH ranged from 8 to 10. No correlation was observed with these two parameters and the isolation of phages.

Figure 1
Figure 1.

Click to view enlarged image

Figure 1. Electron micrograph of O34 vibriophage. Bar represents 100 nm.

  

Figure 2

Figure 2.
Click to view enlarged image

Figure 2. Electron micrograph of O6 vibriophage. Bar represents 100 nm.

The morphology of the phages was studied by negative staining electron microscopy. The O34 phages have a hexagonal head with a long tail. The diameter (distance between opposite apices) of the head is 83.0 ± 0.3 nm, while the length and width of the tail are 111.0 ± 0.8 nm and 17.0 ± 0.5 nm, respectively (Figure 1). The O6 phage has a similar form, with a head diameter of 77.5 ± 0.3 nm and a long tail 100.0 ± 0.6 nm in length and 19.0 ± 0.4 nm in width (Figure 2). The other enteropathogens isolated from the sewage samples were enteropathogenic Escherichia coli, Salmonella spp., and Shigella spp. (data not shown).

The use of vibriophages as tools for studying the source or origin of V. cholerae has contributed greatly to the understanding of the epidemiology of this disease. The emergence of V. cholerae O1 in South America in 1991 provoked major social and economic damage. A total of 60,000 clinical cases were reported from 1990 to 1996 in the coastal city of Rio de Janeiro. In 1997, approximately 2,600 confirmed cases of cholera were reported. In 1998, the number of cholera cases was 376. In 1999, the number of cases increased to 4,142; in 2000, the number decreased to 821 cases. This extreme variation in cholera cases continued during 2001, 2002, and 2003 (until February): the number of cholera cases reported were 665, 174, and 10, respectively. However, since 1993, no cholera cases caused by O1 have been reported. Only cases of non-O1 have been encountered, with O6 and O34 the predominant serotypes. A nationwide survey conducted by the National Reference Center for Cholera under Instituto Oswaldo Cruz is ongoing to isolate more phages in Brazil and neighboring countries.

To date, serotyping is the only identification tool for the characterization of non-O1 strains of V. cholerae (8). However, serotyping is only performed at a limited number of laboratories. For this study, all isolates from Brazil were sent to laboratories outside the country for serotyping. This step was expensive and time-consuming and posed risks during transit.

An alternative method is the use of phages for identifying non-O1 strains. This method offers an affordable monitoring system in less-developed countries such as Brazil. Phage O6 and O34 should at least be useful for confirming the diagnosis of V. cholerae O6 and O34 infection and for differentiating V. cholerae O1 and non-O1 strains.

Acknowledgment

The authors are grateful to Eliseu Alves Waldman, University of Sao Paulo, Brazil for providing valuable information.

References

  1. Sarkar BL. A new phage-typing scheme for Vibrio cholerae biotype ElTor developed at the National Institute of Cholera and Enteric Diseases, Calcutta, India. Indian Journal of Medical Research Bulletin 1993;23:82–3.
  2. Sarkar BL, Roy MK, Chakraborti AK, Niyogi SK. Distribution of phage type of Vibrio cholerae O1 biotype in Indian Scenario (1991–98). Indian J Med Res 1999;109:204–7.
  3. Chakrabarti AK, Ghosh AN, Nair GB, Niyogi SK, Bhattacharya SK, Sarkar BL. Development and evolution of a phage typing scheme for Vibrio cholerae O139. J Clin Microbiol 2000;38:44–9.
  4. Rodrigues DP, Seki LM, Sarkar BL. The use of phage typing scheme in Vibrio cholerae strains isolated in Brazil. Proc. 33rd US-Japan cholera and related diarrhoeal diseases joint panel meeting, Dec 3–5, 1997. Clearwater Beach (FL): U.S.-Japan Cooperative Medical Science Program; 1997. p. 188.
  5. Chattopadhyay DJ, Sarkar BL, Ansari MQ, Chakrabarti BK, Roy MK, Ghosh AN, et al. New phage typing scheme for Vibrio cholerae O1 biotype El Tor strains. J Clin Microbiol 1993;31:1579–85.
  6. Chakrabarti AK, Ghosh AN, Sarkar BL. Isolation of Vibrio cholerae O139 phages to develop a phage typing scheme. Indian J Med Res 1997;105:254–7.
  7. Ghosh AN, Ansari MQ, Dutta GC. Isolation and morphological characterization of ElT or cholera phages. J Gen Virol 1989;70:2241–3.
  8. Sarkar BL. Cholera bacteriophages revisited. ICMR Bull 2002;32:33–7.
   
     
   
Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

B.L. Sarkar, National Institute of Cholera & Enteric Diseases (ICMR) WHO Collaborating Centre for Research and Training on Diarrheal Diseases, P-33, C.I.T. Road, Scheme–XM, Beleghata, Kolkata 700010, India; fax: +91-33-2350-506; email: bl_sarkar@hotmail.com

Return email address optional:


 


Comments to the EID Editors
Please contact the EID Editors at eideditor@cdc.gov

Email this article

Your email:

Your friend's email:

Message (optional):

 

 

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page posted March 9, 2004
This page last reviewed April 23, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention